Radiographic features of patients with chronic granulomatous disease
Abstract
Introduction: Chronic granulomatous disease (CGD) is one of the most common primary immunodeficiencies of childhood, and is caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex. Alongside neutrophil dysfunction, dysregulation of the immune system predisposes patients to recurrent life-threatening infections as well as granuloma formation, hyperinflammation, and autoimmunity. Examination by imaging (radiography, ultrasound, computed tomography, magnetic resonance) in conjunction with biopsy and tissue or fluid cultures are essential to identify the extent and severity of infections as well as the microorganisms responsible. These modalities also help to guide the management of inflammatory complications.
Aim: We highlight the common radiographic findings in 10 pediatric CGD patients followed at our centre over a period of 10 years.
Methods: Medical records of patients with confirmed CGD diagnosis were reviewed retrospectively. All had low neutrophil oxidative burst index (NOBI) and pathogenic mutation in 1 of the 5 subunits of the NADPH oxidase. Three patients had autosomal recessive CGD and 7 had X-linked recessive CGD. All but 1 are male.
Results: The most common radiographic presentation was hilar lymphadenopathy and pulmonary nodules. Other lung complications include cavitating lesions, lung abscess, pulmonary nodule, and pleuritic nodules. Lymphatic tissue and lymph nodes were involved in 50% of our cohort of patients, while gastrointestinal manifestations were noted in approximately 35% of our patients. These include the presence of pigmented macrophages, multiple granulomas, liver abscess, or detection of Aspergillus in tissue or fluid culture.
Discussion: It is essential for clinicians to keep primary immunodeficiency as one of the differential diagnoses in patients who present with severe infection or inflammation. We encourage physicians to consider CGD in patients with above described findings and consider measuring NOBI in patients with early onset infection, inflammation, or granuloma formation.
Statement of novelty: We describe the radiographic findings of a pediatric cohort of patients with CGD.
Formats available
You can view the full content in the following formats:
REFERENCES
Ahlin A., Fugelang J., de Boer M., Ringden O., Fasth A., and Winiarski J. 2013. Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr. 102: 1087–1094.
Battersby A.C., Cale A.M., Goldblatt D., and Gennery A.R. 2013. Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease. J. Clin. Immunol. 33: 1276–1284.
Cale C.M., Jones A.M., and Goldblatt D. 2000. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin. Exp. Immunol. 120: 351–355.
Connelly J.A., Marsh R., Parikh S., and Talano J.A. 2018. Allogeneic hematopoietic cell transplantation for chronic granulomatous disease: Controversies and state of the art. J. Pediatric Infect. Dis. Soc. 7: S31–S39.
De Ravin S.S., Naumann N., Cowen E.W., Friend J., Hilligoss D., Marquesen M., Balow J.E., Barron K.S., Turner M.L., Gallin J.I., and Malech H.L. 2008. Chronic granulomatous disease as a risk factor for autoimmune disease. J. Allergy Clin. Immunol. 122: 1097–1103.
Guide S.V., Stock F., Gill V.J., Anderson V.L., Malech H.L., Gallin J.I., and Holland S.M. 2003. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J. Infect. Dis. 187: 845–853.
Ho C.M., Vowels M.R., Lockwood L., and Ziegler J.B. 1996. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant. 18: 213–215.
Kaplan E.L., Laxdal T., and Quie P.G. 1968. Studies of polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: Bactericidal capacity for streptococci. Pediatrics, 41: 591–599.
Kaufmann K.B., Chiriaco M., Siler U., Finocchi A., Reichenbach J., Stein S., and Grez M. 2014. Gene therapy for chronic granulomatous disease: Current status and future perspectives. Curr. Gene Ther. 14: 447–460.
Kohn D.B. 2010. Update on gene therapy for immunodeficiencies. Clin. Immunol. 135: 247–254.
Köker M.Y., Camcıoğlu Y., van Leeuwen K., Kılıç S.Ş., Barlan I., Yılmaz M., Metin A., de Boer M., Avcılar H., Patıroğlu T., Yıldıran A., Yeğin O., Tezcan I., Sanal Ö., and Roos D. 2013. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J. Allergy Clin. Immunol. 132: 1156–1163.e5.
Kuhns D.B., Alvord W.G., Heller T., Feld J.J., Pike K.M., Marciano B.E., Uzel G., DeRavin S.S., Priel D.A., Soule B.P., Zarember K.A., Malech H.L., Holland S.M., and Gallin J.I. 2010. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363: 2600–2610.
Lazarus G.M. and Neu H.C. 1975. Agents responsible for infection in chronic granulomatous disease of childhood. J. Pediatr. 86: 415–417.
Mahdaviani S.A., Mohajerani S.A., Rezaei N., Casanova J.L., Mansouri S.D., and Velayati A.A. 2013. Pulmonary manifestations of chronic granulomatous disease. Expert Rev. Clin. Immunol. 9: 153–160.
Marciano B.E., Rosenzweig S.D., Kleiner D.E., Anderson V.L., Darnell D.N., Anaya-O’Brien S., Hilligoss D.M., Malech H.L., Gallin J.I., and Holland S.M. 2004. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics, 114: 462–468.
Marciano B.E., Zerbe C.S., Falcone E.L., Ding L., DeRavin S.S., Daub J., Kreuzburg S., Yockey L., Hunsberger S., Foruraghi L., Barnhart L.A., Matharu K., Anderson V., Darnell D.N., Frein C., Fink D.L., Lau K.P., Long Priel D.A., Gallin J.I., Malech H.L., Uzel G., Freeman A.F., Kuhns D.B., Rosenzweig S.D., and Holland S.M. 2018. X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability. J. Allergy Clin. Immunol. 141: 365–371.
Matute J.D., Arias A.A., Wright N.A., Wrobel I., Waterhouse C.C., Li X.J., Marchal C.C., Stull N.D., Lewis D.B., Steele M., Kellner J.D., Yu W., Meroueh S.O., Nauseef W.M., and Dinauer M.C. 2009. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood, 114: 3309–3315.
Murguia-Favela L. and Manson D. 2014. Imaging in patients with chronic granulomatous disease. LymphoSign J. 1: 105–120.
Roos D. and de Boer M. 2014. Molecular diagnosis of chronic granulomatous disease. Clin. Exp. Immunol. 175: 139–149.
Schappi M.G., Jaquet V., Belli D.C., and Krause K.H. 2008. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin. Immunopathol. 30: 255–271.
Seger R.A., Gungor T., Belohradsky B.H., Blanche S., Bordigoni P., Di Bartolomeo P., Flood T., Landais P., Müller S., Ozsahin H., Passwell J.H., Porta F., Slavin S., Wulffraat N., Zintl F., Nagler A., Cant A., and Fischer A. 2002. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: A survey of the European experience, 1985–2000. Blood, 100: 4344–4350.
Thomsen I.P., Smith M.A., Holland S.M., and Creech C.B. 2016. A comprehensive approach to the management of children and adults with chronic granulomatous disease. J. Allergy Clin. Immunol. Pract. 4: 1082–1088.
Towbin A.J. and Chaves I. 2010. Chronic granulomatous disease. Pediatr. Radiol. 40: 657–668; quiz 792–793.
Winkelstein J.A., Marino M.C., Johnston R.B. Jr., Boyle J., Curnutte J., Gallin J.I., Malech H.L., Holland S.M., Ochs H., Quie P., Buckley R.H., Foster C.B., Chanock S.J., and Dickler H. 2000. Chronic granulomatous disease: Report on a national registry of 368 patients. Medicine, 79: 155–169.
Information & Authors
Information
Published In
LymphoSign Journal
Volume 7 • Number 2 • June 2020
Pages: 66 - 80
History
Received: 10 January 2020
Accepted: 24 February 2020
Accepted manuscript online: 19 April 2020
Copyright
© 2020.
Authors
Metrics & Citations
Metrics
Other Metrics
Citations
Cite As
PariaKashani, LaraFarras Roca, and DavidManson. 2020. Radiographic features of patients with chronic granulomatous disease. LymphoSign Journal.
7(2): 66-80. https://doi.org/10.14785/lymphosign-2020-0002
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
There are no citations for this item
View Options
Get Access
Login options
Check if you access through your login credentials or your institution to get full access on this article.
